Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$11.82
-0.96%
Mkt Cap $1.78B
Analyst Ratings
Buy
8
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
Implied Upside
+98.9%
Consensus $23.50 vs current $11.82
NASDAQ·Healthcare·Biotechnology
$11.82
-0.96%
Mkt Cap $1.78B
Buy
8
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
+98.9%
Consensus $23.50 vs current $11.82